BTLA, His, Cynomolgus
BTLA, His, Cynomolgus

Immobilized BTLA, His, Cynomolgus, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-BTLA Antibody, hFc Tag with the EC50 of 4.9ng/ml determined by ELISA.

BTLA, His, Cynomolgus

The purity of BTLA, His, Cynomolgus is greater than 95% as determined by SEC-HPLC.

BTLA, His, Cynomolgus

BTLA, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

BTLA, His, Cynomolgus

B- and T-lymphocyte attenuator (BTLA; CD272) is a 35 kDa type I transmembrane glycoprotein in the CD28 family of T cell costimulatory molecules. BTLA is a inhibitory receptor on lymphocytes that negatively regulates antigen receptor signaling via PTPN6/SHP-1 and PTPN11/SHP-2. BTLA may interact in cis (on the same cell) or in trans (on other cells) with TNFRSF14.
Z04753
¥72,752.00

Ask us a question
Product Introduction
Species Cynomolgus
Protein Construction
BTLA (Lys31-Pro152)
Accession # A0A2K5W7M7		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 15.04 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 35-40 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • BTLA, His, Cynomolgus
    • BTLA, His, Cynomolgus

    Immobilized BTLA, His, Cynomolgus, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-BTLA Antibody, hFc Tag with the EC50 of 4.9ng/ml determined by ELISA.

  • BTLA, His, Cynomolgus
    • BTLA, His, Cynomolgus

    The purity of BTLA, His, Cynomolgus is greater than 95% as determined by SEC-HPLC.

  • BTLA, His, Cynomolgus
    • BTLA, His, Cynomolgus

    BTLA, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background B- and T-lymphocyte attenuator (BTLA; CD272) is a 35 kDa type I transmembrane glycoprotein in the CD28 family of T cell costimulatory molecules. BTLA is a inhibitory receptor on lymphocytes that negatively regulates antigen receptor signaling via PTPN6/SHP-1 and PTPN11/SHP-2. BTLA may interact in cis (on the same cell) or in trans (on other cells) with TNFRSF14.
Synonyms CD272; BTLA; BTLA1; FLJ16065; MGC129743

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.